Combined General Meeting of 1 June 2012

This article or press release has no online content. Please download the associated documents for more information.

Associated Documents

1-ipsen-avis-prealable-balo-06042012.pdf
2-ipsen-06042012_ddroits-de-vote-gb.pdf
3-avis-de-convocation-balo-04052012.pdf
4-shareholders-meeting-notice-2012.pdf
5-formulaire-ag-01062012_0.pdf
6-2011-registration-document.pdf
7-communique-mise-a-dispo-doc-ag-gb.pdf
8-presentation-agm-1-juin-2012.pdf
9-ipsen-sa-ag-1-juin-2012-resultats-va.pdf

Ipsen’s first clinical trial lay summary developed with patients, for patients

Ipsen and Blueprint enter exclusive agreement in FOP

Rethink liver cancer: Increase your understanding this Liver Cancer Awareness Month

Ipsen in Oncology: For us, it’s personal

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2019